tiprankstipranks
Trending News
More News >
Aptose Biosciences (TSE:APS)
TSX:APS
Canadian Market

Aptose Biosciences (APS) Income Statement

Compare
146 Followers

Aptose Biosciences Income Statement

Last quarter (Q3 2025), Aptose Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aptose Biosciences's net income was $-5.12M. See Aptose Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -474.55K$ -507.08K$ -616.53K$ -646.43K
Operating Expenses
$ 26.26M$ 52.36M$ 42.60M$ 65.45M$ 55.77M
Depreciation and Amortization
$ 32.00K$ 88.00K$ 120.00K$ 150.00K$ 646.43K
EBITDA
$ -26.23M$ -52.27M$ -42.48M$ -65.30M$ -55.12M
Operating Income
$ -26.26M$ -52.36M$ -42.60M$ -65.45M$ -55.77M
Other Income/Expenses
$ 827.00K$ 1.15M$ 779.00K$ 93.00K$ 530.00K
Pretax Income
$ -25.43M$ -51.21M$ -41.82M$ -65.35M$ -55.24M
Net Income
$ -25.43M$ -51.21M$ -41.82M$ -65.35M$ -55.24M
Per Share Metrics
Basic EPS
$ -0.04$ -7.58$ -6.80$ -11.01$ -9.30
Diluted EPS
$ -0.13$ -7.58$ -6.80$ -11.00$ -18.65
Weighted Average Shares Outstanding
698.98M 6.75M 6.15M 5.94M 5.94M
Weighted Average Shares Outstanding (Diluted)
197.70M 6.75M 6.15M 4.56M 2.96M
Currency in USD

Aptose Biosciences Earnings and Revenue History